Letters to the Editor

Retrospective cohort study of treatment with BCL-2 inhibitor venetoclax in advanced AL amyloidosis

University of Heidelberg, Department of Internal Medicine V, Heidelberg
University of Heidelberg, Department of Internal Medicine V, Heidelberg
University of Heidelberg, Department of Internal Medicine V, Heidelberg
Department of Oncology and Hematology, Klinikum Oldenburg, University Medicine Oldenburg, Oldenburg
University of Heidelberg, Institute of Human Genetics, Heidelberg
University of Heidelberg, Institute of Human Genetics, Heidelberg
University of Heidelberg, Department of Internal Medicine V, Heidelberg
University of Heidelberg, Department of Internal Medicine V, Heidelberg
University of Heidelberg, Department of Internal Medicine V, Heidelberg
Haematologica Early view Jun 11, 2026 https://doi.org/10.3324/haematol.2025.288635